ALVET - Company finances
|
EUR
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 10,191 | 23,300 | 43,581 | 46,100 | 75,382 | 76,197 |
| Profit before tax | -3,394 | - | -2,734 | 4,493 | 11,497 | 10,987 |
| Net profit | -3,394 | -3,363 | -2,734 | 4,268 | 10,922 | 10,313 |
| Equity | 5,542 | 2,177 | -557 | 3,711 | 14,633 | 24,945 |
| Liabilities | 46,477 | 41,325 | 41,393 | 37,957 | 35,166 | 33,103 |
| Non-current assets | 5,206 | 3,818 | 2,430 | 1,042 | 0 | 505 |
| Current assets | 46,813 | 39,684 | 38,406 | 40,626 | 49,799 | 57,253 |
| Total assets | 52,019 | 43,502 | 40,836 | 41,668 | 49,799 | 57,758 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 8,784 | 15,047 | 15,410 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +128.6% | +87.0% | +5.8% | +63.5% | +1.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -6.5% | -7.7% | -6.7% | 10.2% | 21.9% | 17.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -61.2% | -154.5% | - | 115.0% | 74.6% | 41.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -33.3% | -14.4% | -6.3% | 9.3% | 14.5% | 13.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -33.3% | - | -6.3% | 9.7% | 15.3% | 14.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 8.4 | 19.0 | - | 10.2 | 2.4 | 1.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,096 | 11,650 | 21,791 | 23,050 | 37,691 | 38,099 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ALVET - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-02-10 | 2022-02-14 | 0.14 |
| 2021-11-16 | 2021-11-24 | 42.21 |
ALVET - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-29 | 2025-08-12 | 0.35 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ALVET, UAB (code 302482185) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 76.2K in revenue and EUR 10.3K in net profit, with a profit margin of 13.5%. Revenue increased by 1.1% year on year, while the two-year growth rate was 65.3%, showing a clear expansion from EUR 46.1K in 2023 to EUR 75.4K in 2024 and EUR 76.2K in 2025. Net profit also improved from EUR 4.3K in 2023 to EUR 10.9K in 2024, before easing slightly to EUR 10.3K in 2025. At the same time, equity strengthened from EUR 3.7K in 2023 to EUR 24.9K in 2025, while liabilities declined from EUR 38.0K to EUR 33.1K. Total assets rose from EUR 41.7K to EUR 57.8K over the same period. For 2025, return on equity was 41.3%, return on assets 17.9%, debt-to-equity 1.33, and asset turnover 1.32x. Revenue per employee was EUR 38.1K, with profit per employee of EUR 5.2K.